Investment
Features
FeesSafety
Academy
More
Pluang+

Nicholas Crypto Income ETF offers 36% annual yield with monthly payouts, outperforming S&P 500 recently.

Analyst Insights
21 May 2026
Seeking Alpha
View Source
Bullish
Nicholas Crypto Income ETF offers 36% annual yield with monthly payouts, outperforming S&P 500 recently.

The Nicholas Crypto Income ETF (BLOX) provides a high estimated annualized distribution rate of 36%, paid monthly, focusing on Bitcoin and Ethereum assets combined with common equities and an active option-writing strategy. Despite some share price volatility, BLOX's total returns, including dividends, have recently outpaced the S&P 500. Its active management approach allows adjustments in option exposure to balance potential gains and risks based on market conditions. This structure aims to deliver strong income alongside growth potential for investors.

More News

VINCI wins €165M contract to build cooling plant for Iberian data center campus

VINCI wins €165M contract to build cooling plant for Iberian data center campus

VINCI's subsidiary Cobra IS secured a €165 million contract to construct a cooling plant for a major data center campus in the Iberian Peninsula. The project involves installing mechanical, electrical, and plumbing systems for 126 dry coolers, which ...

Market News
Bullish
2 hours ago
VINCI wins €165M contract for cooling system in large Iberian data center campus

VINCI wins €165M contract for cooling system in large Iberian data center campus

VINCI's subsidiary Cobra IS secured a €165 million contract to build the cooling system for a massive data center campus in the Iberian Peninsula. The project includes installing mechanical, electrical, and plumbing equipment for 126 air cooling unit...

Market News
Bullish
2 hours ago
Basilea presents new data on antifungals fosmanogepix, isavuconazole, and antibiotic ceftobiprole at IDWeek 2026

Basilea presents new data on antifungals fosmanogepix, isavuconazole, and antibiotic ceftobiprole at IDWeek 2026

Basilea Pharmaceutica announced new clinical and activity data for its antifungal drugs fosmanogepix and isavuconazole, as well as the antibiotic ceftobiprole, to be presented at IDWeek 2026 in Washington D.C. Highlights include pediatric data from f...

Market News
Bullish
3 hours ago
Gainsight launches AI-native Atlas managing $75M ARR and new value-based pricing for customer retention.

Gainsight launches AI-native Atlas managing $75M ARR and new value-based pricing for customer retention.

Gainsight introduced its AI-native services business, Atlas, which manages over $75 million in annual recurring revenue (ARR) by handling long-tail customer renewals with AI agents and human managers. The company also announced a shift to value-based...

Market News
Bullish
4 hours ago
$55M flows into volatile triple-leveraged biotech ETF despite 5-year losses

$55M flows into volatile triple-leveraged biotech ETF despite 5-year losses

Traders poured $54.6 million into the Direxion Daily S&P Biotech Bull 3X ETF (LABU) on October 14, 2026, marking the largest inflow relative to its $597 million size. LABU offers triple daily exposure to biotech stocks, making it highly volatile and ...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App